Bristol-Myers Squibb Company (BMY) Management Presents at Citi 15th Annual Biopharma Conference (Transcript)Seeking Alpha • 09/09/20
Bristol Myers Squibb Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers with High Unmet Medical NeedBusiness Wire • 09/08/20
Bristol Myers Squibb (BMY) Stock Moves -0.17%: What You Should KnowZacks Investment Research • 09/04/20
Bristol Myers Squibb to Participate in Citi’s 15th Annual BioPharma Virtual ConferenceBusiness Wire • 09/02/20
Bristol Myers Squibb Announces Interim Results from Long-Term Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple SclerosisBusiness Wire • 09/01/20
Bristol Myers Is Launching A New MS Drug — But Is BMY Stock A Buy?Investors Business Daily • 08/26/20
Bristol Myers Squibb Provides Update on Phase 3 IDHENTIFY Trial in Patients with Relapsed or Refractory Acute Myeloid LeukemiaBusiness Wire • 08/25/20
Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta Asset to PortfolioBusiness Wire • 08/24/20